Phase 2 Hematological Malignancy Clinical Trials
7 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–7 of 7 trials
Recruiting
Phase 1Phase 2
Study to Evaluate the Safety and Effectiveness of Withaferin A as a Treatment to Prevent GvHD in Transplant Patients
Hematopoietic Stem Cell Transplant (HSCT)Hematological MalignancyGVHD - Graft-Versus-Host Disease
Tata Memorial Centre54 enrolled2 locationsNCT07724873
Recruiting
Phase 2
Study of Standardized Withaferin-A for the Treatment of Steroid Refractory Acute Graft Versus Host Disease.
Hematological MalignancyGVHD - Graft-Versus-Host DiseaseSteriod Refractory
Tata Memorial Centre34 enrolled1 locationNCT07708987
Recruiting
Phase 2
Prospective Evaluation of Xerava Prophylaxis in Hematological Malignancy Patients With Prolonged Neutropenia
NeutropeniaHematological Malignancy
West Virginia University55 enrolled1 locationNCT05537896
Recruiting
Phase 2
HLA-Haploidentical Peripheral Blood Stem Cell Transplantation With Post-transplant Cyclophosphamide and Bortezomib
Hematological Malignancy
Henry Ford Health System15 enrolled1 locationNCT03850366
Recruiting
Phase 1Phase 2
Phase I/II Study of CD5 CAR Engineered IL15-Transduced Cord Blood-Derived NK Cells in Conjunction With Lymphodepleting Chemotherapy for the Management of Relapsed/Refractory Hematological Malignances
Hematological Malignancy
M.D. Anderson Cancer Center64 enrolled1 locationNCT05110742
Recruiting
Phase 1Phase 2
GT719 Injection for the Treatment of Recurrent/Refractory CD19 Positive Adult B-cell Malignancies
Hematological Malignancy (Leukemia- Lymphoma)
Grit Biotechnology46 enrolled1 locationNCT06948981
Recruiting
Phase 2
Thymalfasin and Recombinant Human IL-2 Injections in Treating Lymphocytopenia for Patients With Malignant Hematological Tumors
Hematological MalignancyLymphocytopenia
The First Affiliated Hospital of Xiamen University50 enrolled1 locationNCT06584006